On September 17, 2019, IDL Biotech will launch the company’s rapid test for typhoid fever, TUBEX TF, in Kenya.
Read more here
On September 17, 2019, IDL Biotech will launch the company’s rapid test for typhoid fever, TUBEX TF, in Kenya.
Read more here
IDL Biotech continues to expand in Africa. IDL Biotech has signed a distributor agreement with Res Health Consult Ltd covering Ghana. The agreement covers the sale of TUBEX® TF. Since its launch in Africa, the company has focused on finding the right partners for...
IDL Biotech continues to expand in Africa. Today, IDL Biotech has signed a distributor agreement with Roi Scientific Ltd covering Rwanda, South Sudan and Somalia. The agreement covers the sale of TUBEX® TF. Since its launch in Africa, the company has focused on...